These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19099641)

  • 1. [Correlation between CD34+CD61+ megakaryocyte precursors and platelet engraftment in allogeneic hematopoietic stem cell transplantation].
    Zhou LK; Chen HR; Wang HX; Yan HM; Duan LN; Zhu L; Xue M; Liu J; Ji SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1344-9. PubMed ID: 19099641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation.
    Demirer T; Ilhan O; Arat M; Genç Y; Ozcan M; Dalva K; Celebi H; Beksaç M; Akan H; Gürman G; Konuk N; Uysal A; Arslan O; Koç H
    J Clin Apher; 2001; 16(2):67-73. PubMed ID: 11746531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation.
    Woo KS; Goh RY; Kim SH; Kwon HC; Kim HJ; Lee YH; Han JY
    Cytotherapy; 2007; 9(6):555-61. PubMed ID: 17882720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of megakaryocyte precursors in peripheral blood stem cell collections from normal donors.
    Bojko P; Hester JP; Durett AG; Maadani F; Körbling M; Champlin RE
    J Clin Apher; 1998; 13(1):7-15. PubMed ID: 9590491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
    Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
    Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CD34 subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation.
    Kamel AM; El-Sharkawy N; Mahmoud HK; Khalaf MR; El Haddad A; Fahmy O; El Fattah RA; Sayed D
    Bone Marrow Transplant; 2005 Jan; 35(2):129-36. PubMed ID: 15568034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.
    Drayer AL; Smit Sibinga CT; Esselink MT; de Wolf JT; Vellenga E
    Ann Hematol; 2002 Apr; 81(4):192-7. PubMed ID: 11976820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.
    Lickliter JD; McGlave PB; DeFor TE; Miller JS; Ramsay NK; Verfaillie CM; Burns LJ; Wagner JE; Eastlund T; Dusenbery K; Weisdorf DJ
    Bone Marrow Transplant; 2000 Oct; 26(7):723-8. PubMed ID: 11042652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors influencing engraftment in hematological patients after human leukocyte antigen matched sibling allogeneic blood and marrow transplantation].
    Chang YJ; Liu DH; Xu LP; Liu KY; Chen YH; Chen H; Zhao XY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):647-50. PubMed ID: 19954056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic peripheral blood stem cell transplantation and early detection of donor engraftment by polymerase chain reaction.
    Tzeng CH; Lyou JY; Lin JS; Chen YR; Hu HY; Yung CH; Wang SY; Lee JC
    J Formos Med Assoc; 1998 Apr; 97(4):252-60. PubMed ID: 9585676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
    Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
    Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haploidentical allogeneic bone marrow stem cell transplantation combined with peripheral blood stem cells for therapy of leukemia].
    Yan HM; Xue M; Wang ZD; Zhu L; Liu J; Ding L; Pan SP; Duan LN; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1330-4. PubMed ID: 19840477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic and immune recovery after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation in a pediatric population.
    Nagatoshi Y; Kawano Y; Watanabe T; Abe T; Okamoto Y; Kuroda Y; Takaue Y; Okamura J
    Pediatr Transplant; 2002 Aug; 6(4):319-26. PubMed ID: 12234273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?
    Singhal S; Powles R; Treleaven J; Kulkarni S; Sirohi B; Horton C; Millar B; Shepherd V; Tait D; Saso R; Rowland A; Long S; Mehta J
    Bone Marrow Transplant; 2000 Sep; 26(5):489-96. PubMed ID: 11019837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing engraftment in HLA-haploidentical/mismatch related transplantation with combined granulocyte-colony stimulating factor-mobilized peripheral blood and bone marrow for patients with leukemia.
    Zhang C; Zhang X; Chen XH; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Wang QY
    Transfus Apher Sci; 2011 Jun; 44(3):249-55. PubMed ID: 21550308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.